Says to recall 12,200 devices To take related charge of $2-$3 mln in Q4 Sees related cash expenditures in H1, 2010 Shares fall 3 pct after the bell Feb 3 (Reuters) - Cardiac Science Corp said it will ...
The FDA issued a Class I recall — the most serious recall classification — for some of Medtronic’s cardiac resynchronization therapy and implantable cardioverter defibrillators. Here are four things ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results